Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
ConocoPhillips
COP
|
$3.33B |
| 2 |
Merck
MRK
|
$2.61B |
| 3 |
Schlumberger
SLB
|
$1.65B |
| 4 |
Target
TGT
|
$1.34B |
| 5 |
General Mills
GIS
|
$926M |
Top Sells
| 1 |
Pfizer
PFE
|
$2.72B |
| 2 |
Blackrock
BLK
|
$2.48B |
| 3 |
US Bancorp
USB
|
$1.68B |
| 4 |
M&T Bank
MTB
|
$762M |
| 5 |
Huntington Bancshares
HBAN
|
$554M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Aclaris Therapeutics
ACRS
$209M
| $50.6K | ﹤0.01% |
33,079
| – | – |
|
3402
DiaMedica Therapeutics
DMAC
$295M
| $50.2K | ﹤0.01% |
13,253
+2
| +0% | +$8 |
|
3403
Atomera
ATOM
$103M
| $50K | ﹤0.01% |
12,489
+1
| +0% | +$4 |
|
|
CHMI
3404
Cherry Hill Mortgage Investment Corp
CHMI
$103M
| $49.5K | ﹤0.01% |
15,001
| – | – |
|
3405
Sagimet Biosciences
SGMT
$244M
| $48.9K | ﹤0.01% |
+15,000
| New | +$48.9K |
|
3406
RenovoRx
RNXT
$35.2M
| $48.7K | ﹤0.01% |
49,232
| – | – |
|
3407
Lightpath Technologies
LPTH
$230M
| $48.6K | ﹤0.01% |
24,173
| – | – |
|
|
HURA
3408
TuHURA Biosciences, Inc. Common Stock
HURA
$135M
| $48.5K | ﹤0.01% |
15,000
| – | – |
|
3409
MarketWise
MKTW
$49.6M
| $48.3K | ﹤0.01% |
97,783
| – | – |
|
|
IVAC
3410
DELISTED
Intevac Inc
IVAC
| $47.5K | ﹤0.01% |
11,887
| – | – |
|
3411
Genasys
GNSS
$87.6M
| $47.5K | ﹤0.01% |
20,918
| – | – |
|
|
ELEV
3412
DELISTED
Elevation Oncology
ELEV
| $47.1K | ﹤0.01% |
181,694
+57,513
| +46% | +$14.9K |
|
3413
Research Solutions
RSSS
$98.3M
| $47K | ﹤0.01% |
18,069
| – | – |
|
3414
Veritone
VERI
$169M
| $46.5K | ﹤0.01% |
20,000
| – | – |
|
3415
Kopin
KOPN
$342M
| $46.5K | ﹤0.01% |
49,841
-76,051
| -60% | -$70.9K |
|
3416
Smart Sand
SND
$77.1M
| $45.2K | ﹤0.01% |
17,439
| – | – |
|
3417
Verrica Pharmaceuticals
VRCA
$52.8M
| $44K | ﹤0.01% |
99,505
+55,852
| +128% | +$24.7K |
|
3418
Outlook Therapeutics
OTLK
$37.8M
| $44K | ﹤0.01% |
36,060
+12
| +0% | +$15 |
|
3419
Zevia
ZVIA
$210M
| $43.2K | ﹤0.01% |
20,011
| – | – |
|
3420
Ovid Therapeutics
OVID
$91M
| $42.3K | ﹤0.01% |
135,487
-26,321
| -16% | -$8.21K |
|
3421
PetMed Express
PETS
$63.4M
| $41.9K | ﹤0.01% |
10,000
-99,186
| -91% | -$416K |
|
3422
Offerpad Solutions
OPAD
$158M
| $41.6K | ﹤0.01% |
25,044
-8,794
| -26% | -$14.6K |
|
3423
Grove Collaborative
GROV
$62.3M
| $41.2K | ﹤0.01% |
30,520
| – | – |
|
3424
Origin Materials
ORGN
$80.2M
| $39.8K | ﹤0.01% |
60,039
+39
| +0.1% | +$26 |
|
3425
Marchex
MCHX
$86.6M
| $39.6K | ﹤0.01% |
24,313
| – | – |
|